Moreover, PASI 90 and PASI 100 scores were the highest for the head and neck region, indicating the highest response rates, while those for the lower extremities were consistently low at all visits.

It has recently been claimed that patients who achieve PASI scores less than or equal to 2 within the first 6 months of initiating biologic treatment tend to exhibit more stable psoriasis and a ...

The rates of response were 53%, 61%, and 64% for the 20-mg, 30-mg, ... At 4 weeks, PASI scores climbed from baseline by nearly 40% for those on all orismilast doses, ...

Of the 230 patients who received continuous deucravacitinib treatment and achieved PASI 75 by week 24, 60.9% achieved PASI 90 and 82.2% achieved sPGA 0/1. Response rates were generally maintained ...

The proportion of patients who achieved a PASI 100 score, signifying total clearance, approached 70% at 4 years in the group with the greatest response. PASI 90 and PASI 100 rates at this point ...

Of the patients who had a PASI 75 response at week 24, 82% (187/228) had this continued response at week 52. For those who had a PASI 90 response at week 24, 74% (103/140) had this continued ...

PASI 100 rates at the same time points were 27% and 40% among patients switched from placebo to icotrokinra. IGA 0 response rate increased from 1% at 16 weeks to 23% at 24 weeks, and PASI 100 ...

Although there was no statistically significant difference between the proportion of patients who achieved a PASI-50 response on EDP2939 compared to placebo, it was notable that such numeric ...

The mid-stage study did not achieve its primary endpoint of difference in the proportion of patients who achieved at least 50% improvement from baseline in PASI score (a PASI-50 response) between ...

Meanwhile, 49.6% of patients saw a 90% or more improvement in a Psoriasis Area and Severity Index (PASI 90) score from baseline, meeting the other co-primary goal. Of those on placebo, 4.4% met ...

“The study’s primary endpoint, the difference in the proportion of patients who achieved an outcome of a 50% improvement from baseline in Psoriasis Area and Severity Index (PASI) score (a PASI ...